Viatris Inc (VTRS) stock

VTRSNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3010% below fair value

$20.82+0.15 (+0.73%)

Close on Nov 13, 2026Market cap $23.91BP/E –Yield 2.31%

Viatris gross margin

Gross margin is gross profit as a percentage of revenue.

Viatris's gross margin for the twelve months ending Sep 30, 2026 was 35.3%. For fiscal 2025 it was 35.1%, against 38.2% the year before. The highest annual figure on record is 41.7% in fiscal 2023.

Annual gross margin

Period	Period end	Value	Change (pts)
FY2025	Dec 31, 2025	35.1%	−3.1
FY2024	Dec 31, 2024	38.2%	−3.6
FY2023	Dec 31, 2023	41.7%	+1.8
FY2022	Dec 31, 2022	40.0%	+8.8
FY2021	Dec 31, 2021	31.2%	−0.6
FY2020	Dec 31, 2020	31.8%	−2.1
FY2019	Dec 31, 2019	33.9%	−1.1
FY2018	Dec 31, 2018	35.0%	–

Quarterly gross margin

Change is against the same quarter a year earlier.

Period	Period end	Value	Change (pts)
Q3 FY2026	Sep 30, 2026	38.4%	+1.9
Q2 FY2026	Jun 30, 2026	38.8%	+1.6
Q1 FY2026	Mar 31, 2026	32.9%	−2.8
Q4 FY2025	Dec 31, 2025	31.0%	−3.4
Q3 FY2025	Sep 30, 2025	36.5%	−2.4
Q2 FY2025	Jun 30, 2025	37.2%	−0.9
Q1 FY2025	Mar 31, 2025	35.7%	−5.4
Q4 FY2024	Dec 31, 2024	34.4%	−7.2
Q3 FY2024	Sep 30, 2024	38.9%	−4.0
Q2 FY2024	Jun 30, 2024	38.1%	−3.0
Q1 FY2024	Mar 31, 2024	41.1%	−0.3
Q4 FY2023	Dec 31, 2023	41.6%	+8.7
Q3 FY2023	Sep 30, 2023	42.9%	+0.0
Q2 FY2023	Jun 30, 2023	41.1%	−0.3
Q1 FY2023	Mar 31, 2023	41.4%	−0.9
Q4 FY2022	Dec 31, 2022	32.9%	−2.7
Q3 FY2022	Sep 30, 2022	42.9%	+8.2
Q2 FY2022	Jun 30, 2022	41.4%	+12.4
Q1 FY2022	Mar 31, 2022	42.3%	+16.8
Q4 FY2021	Dec 31, 2021	35.6%	+16.1
Q3 FY2021	Sep 30, 2021	34.7%	−4.3
Q2 FY2021	Jun 30, 2021	29.0%	−8.6
Q1 FY2021	Mar 31, 2021	25.4%	−9.1
Q4 FY2020	Dec 31, 2020	19.5%	–
Q3 FY2020	Sep 30, 2020	39.0%	–
Q2 FY2020	Jun 30, 2020	37.6%	–
Q1 FY2020	Mar 31, 2020	34.6%	–